Diabetes type1 Clinical Trial
Official title:
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
The purpose of this study is to assess the safety and tolerability of different doses of AG019 administered alone or in combination with teplizumab in participants with recent-onset type 1 diabetes (T1D).
This Phase 1b/2a, multi-center study will be conducted in participants with clinical recent-onset type 1 diabetes (T1D). The primary objective of this study is to assess the safety and tolerability of different doses of AG019 alone as well as AG019 in combination with teplizumab. The secondary objectives of this study are: to obtain pharmacodynamic (PD) data of AG019 alone as well as AG019 in combination with teplizumab; and to determine the potential presence of AG019 in systemic circulation (safety - systemic exposure) and the presence of L. lactis bacteria in fecal excretion (local exposure): Pharmacokinetic (PK) profile. This study consists of 2 phases: Phase 1b: this open-label part of the study will investigate the safety and tolerability of 2 different doses of AG019 in 2 age groups (18-40 years of age and 12-17 years of age). Phase 2a: this randomized, double-blind part of the study will investigate the safety and tolerability of AG019, in combination with teplizumab, in 2 age groups (18-40 years of age and 12-17 years of age). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05437913 -
Protocol for Self-Compassion Intervention for Teens With Diabetes Type 1 and Their Caregivers
|
N/A | |
| Recruiting |
NCT03565770 -
Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children
|
N/A | |
| Not yet recruiting |
NCT06437782 -
Exploration of Health Literacy in Diabetes in Reunion Island and France
|
||
| Not yet recruiting |
NCT05990933 -
Role of Adrenaline in in the Inflammatory Response in Diabetes
|
N/A | |
| Recruiting |
NCT05669547 -
Dual Hormone Closed Loop in Type 1 Diabetes
|
N/A | |
| Recruiting |
NCT06190756 -
Impact of Gravity on Cardiac Hemodynamics
|
N/A | |
| Completed |
NCT05069727 -
Simple Initiation of Advanced Hybrid Closed Loop System
|
N/A | |
| Recruiting |
NCT06460558 -
T1D Closed-loop and Physical Activity
|
||
| Recruiting |
NCT05866536 -
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
|
Phase 2 | |
| Not yet recruiting |
NCT06405373 -
Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
|
N/A | |
| Not yet recruiting |
NCT06405386 -
Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
|
N/A | |
| Completed |
NCT04635280 -
Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System
|
N/A | |
| Completed |
NCT05168657 -
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
|
N/A | |
| Active, not recruiting |
NCT05574062 -
Evaluation of the MiniMed 780 System in Paediatric Subjects
|
N/A | |
| Recruiting |
NCT05180591 -
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
|
Phase 2 | |
| Recruiting |
NCT05176795 -
Host-microbiota-environment Interactions
|
||
| Completed |
NCT05284071 -
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
|
N/A | |
| Completed |
NCT05933460 -
Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1
|
N/A | |
| Not yet recruiting |
NCT04772729 -
Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?
|
Phase 4 | |
| Not yet recruiting |
NCT03170089 -
Oral Health Awareness and Oral Hygiene in Insulin Dependent Diabetes Mellitus
|
N/A |